Sanofi's new insulin treatment ... starting out with a new or alternate insulin therapy." He added: "As it is well known in clinical practice, many people go through a sensitive phase when ...

Sanofi–Aventis has signed an agreement with CureDM ... a fundamental problem is the loss of functional islet β-cell mass, resulting in insulin deficiency and hyperglycaemia,” explains ...

Sanofi has formed another partnership to support its vision of insulin-based therapies that are connected with glucose monitoring devices and make it easier for patients to manage their blood ...

T he French pharmaceutical company Sanofi has confirmed that it aims to invest €1.3 billion ($1.4 billion) in the construction of a modern insulin production facility at its site near Frankfurt ...

Metabolex has entered into an agreement with Sanofi–Aventis for the development of ... that underlie hyperglycaemia — that is, impaired insulin secretion, inappropriately high glucagon ...

Maine Attorney General Aaron Frey announced a settlement agreement Tuesday with Sanofi-Aventis U.S. following scrutiny over ...

American Diabetes Association (ADA) presents new recommendations in Diabetes Treatment Guidelines - highlighting the efficacy of early addition of insulin ... sponsored by sanofi-aventis ...

Sanofi posted better-than-expected sales and profit in the first quarter on higher demand for its key drugs and vaccines. The French pharmaceutical company said Thursday that business operating ...